Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate

Journal of Alzheimer's Disease : JAD
Mikael EdsbaggeMats Tullberg

Abstract

Neuropathologically, Alzheimer's disease (AD) is characterized by accumulation of a 42 amino acid peptide called amyloid-β (Aβ42) in extracellular senile plaques together with intraneuronal inclusions of hyperphosphorylated tau protein in neurofibrillary tangles and neuronal degeneration. These changes are reflected in the cerebrospinal fluid (CSF), the volumes and production rates of which vary considerably between individuals, by reduced concentration of Aβ42, increased concentration of phosphorylated tau (P-tau) protein, and increased concentration of total tau (T-tau) protein, respectively. To examine the outstanding question if CSF concentrations of AD associated biomarkers are influenced by variations in CSF volumes, CSF production rate, and intracranial pressure in healthy individuals. CSF concentrations of Aβ42, P-tau, and T-tau, as well as a number of other AD-related CSF biomarkers were analyzed together with intracranial subarachnoid, ventricular, and spinal CSF volumes, as assessed by magnetic resonance imaging volumetric measurements, and CSF production rate in 19 cognitively normal healthy subjects (mean age 70.6, SD 3.6 years). Negative correlations were seen between the concentrations of three CSF biomarkers (al...Continue Reading

References

Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
Aug 17, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Mikael EdsbaggeCarsten Wikkelso
Aug 25, 2004·Journal of Internal Medicine·M J de LeonH Rusinek
Jan 8, 2005·Dementia and Geriatric Cognitive Disorders·Brit MollenhauerMarkus Otto
Apr 27, 2005·Annals of Neurology·Murray GrossmanVirginia M-Y Lee
Aug 1, 2006·Lancet·Kaj BlennowHenrik Zetterberg
Sep 18, 2007·Neurobiology of Aging·Andrew J Farrall, Joanna M Wardlaw
Aug 2, 2008·Brain : a Journal of Neurology·Sean M NestorUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 17, 2010·Nature Reviews. Neurology·Kaj BlennowHenrik Zetterberg
Feb 26, 2010·Journal of Alzheimer's Disease : JAD·Brian R OttUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Oct 12, 2010·Lancet Neurology·Bruno DuboisPhilip Scheltens
Mar 18, 2011·Clinical Anatomy : Official Journal of the American Association of Clinical Anatomists & the British Association of Clinical Anatomists·M EdsbaggeC Wikkelso
Feb 22, 2012·Neuromolecular Medicine·Christoffer RosénHenrik Zetterberg
May 5, 2012·AJNR. American Journal of Neuroradiology·K AmbarkiA Eklund
May 21, 2013·FEBS Letters·Natalia N Nalivaeva, Anthony J Turner
Jun 27, 2013·Molecular Neurodegeneration·Christoffer RosénHenrik Zetterberg
Jul 3, 2013·Science·Maiken Nedergaard
Apr 1, 2014·Neurology·Daniel JarajCarsten Wikkelsø
May 6, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Kaj BlennowHarald Hampel
May 29, 2015·Journal of Peptide Science : an Official Publication of the European Peptide Society·Tian QiuYan-Mei Li
May 18, 2016·Behavioural Brain Research·Elliott J MufsonStephen D Ginsberg
Jul 31, 2016·Fluids and Barriers of the CNS·A JeppssonMats Tullberg

❮ Previous
Next ❯

Citations

Jun 27, 2019·Molecular Neurobiology·Soraya Herrera-EspejoÁfrica Garcia-Orad
Apr 18, 2020·Fluids and Barriers of the CNS·Vegard VinjeKaren-Helene Støverud
Mar 16, 2021·Journal of Alzheimer's Disease : JAD·Heikki LukkarinenVille Leinonen
Feb 29, 2020·Neurobiology of Aging·Ehsan TadayonUNKNOWN Alzheimer's Disease Neuroimaging Initiative

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Related Papers

Biochimica Et Biophysica Acta
Ann BrinkmalmHenrik Zetterberg
Alzheimer's Research & Therapy
Jamie ToombsHenrik Zetterberg
Advances in Clinical Chemistry
Henrik ZetterbergKaj Blennow
European Journal of Nuclear Medicine and Molecular Imaging
Marie-Odile HabertMarie Sarazin
Biological Psychiatry
François Mouton-LigerGroupe d'Investigation du Liquide Céphalorachidien Study Network
© 2022 Meta ULC. All rights reserved